WELLINGTON MANAGEMENT GROUP LLP - ZEALAND PHARMA A S ownership

ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 15 filers reported holding ZEALAND PHARMA A S in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of ZEALAND PHARMA A S
ValueSharesWeighting
Q4 2021$1,502,000
-24.6%
70,418
-0.9%
0.00%
Q3 2021$1,992,000
-91.0%
71,040
-90.5%
0.00%
-100.0%
Q2 2021$22,151,000
-24.2%
749,618
-18.0%
0.00%
-20.0%
Q1 2021$29,225,000
-26.0%
914,439
-16.8%
0.01%
-28.6%
Q4 2020$39,517,000
-2.5%
1,099,546
+3.0%
0.01%
-12.5%
Q3 2020$40,549,000
+4.9%
1,067,082
-3.3%
0.01%
-11.1%
Q2 2020$38,640,000
-21.8%
1,103,980
-23.0%
0.01%
-30.8%
Q1 2020$49,442,000
+1.0%
1,433,091
-2.8%
0.01%
+30.0%
Q4 2019$48,970,000
+14.5%
1,475,049
-12.5%
0.01%0.0%
Q3 2019$42,768,000
+12.4%
1,686,496
-4.5%
0.01%
+25.0%
Q2 2019$38,051,000
+27.5%
1,765,664
+0.7%
0.01%
+14.3%
Q1 2019$29,835,000
+42.3%
1,752,954
-2.9%
0.01%
+40.0%
Q4 2018$20,961,000
-33.6%
1,805,515
-5.5%
0.01%
-28.6%
Q3 2018$31,552,000
+31.4%
1,909,983
+0.9%
0.01%
+40.0%
Q2 2018$24,011,000
-17.6%
1,893,621
-2.3%
0.01%
-28.6%
Q1 2018$29,123,000
+34.4%
1,938,996
+21.7%
0.01%
+40.0%
Q4 2017$21,673,000
-28.3%
1,593,675
+1.3%
0.01%
-28.6%
Q3 2017$30,215,0001,573,6360.01%
Other shareholders
ZEALAND PHARMA A S shareholders Q4 2020
NameSharesValueWeighting ↓
FARALLON CAPITAL MANAGEMENT LLC 510,000$18,329,0000.11%
AWM Investment Company, Inc. 19,981$718,0000.09%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 5,653$203,0000.06%
WELLINGTON MANAGEMENT GROUP LLP 1,099,546$39,517,0000.01%
ROYCE & ASSOCIATES LP 10,000$359,0000.00%
Winslow, Evans & Crocker, Inc. 235$8,0000.00%
Renaissance Technologies 17,205$618,0000.00%
JANE STREET GROUP, LLC 35,707$1,283,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Parallel Advisors, LLC 94$3,0000.00%
View complete list of ZEALAND PHARMA A S shareholders